Search clinical trials for: THR-4109
Total 11220 results
-
TheracosTFS Trial Form SupportCompleted
-
Forma Therapeutics, Inc.ProSciento, Inc.TerminatedNonalcoholic Steatohepatitis (NASH) | Overweight or ObesityUnited States
-
MBX BiosciencesCompleted
-
SunovionCompletedDepressive Episode | Bipolar 1 DepressionJapan, Serbia, United States, Poland, Russian Federation, Bulgaria, Slovakia, Ukraine
-
Kissei Pharmaceutical Co., Ltd.Active, not recruitingUterine Fibroids (MeSH Heading: Leiomyoma)Japan
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Sumitomo Pharma America, Inc.TerminatedDepressive Episodes, Bipolar I DepressionUnited States, Bulgaria, Japan, Romania, Canada, Slovakia
-
Innolake BiopharmRecruitingMelanoma | Soft Tissue Sarcoma | Cervical Cancer | Head and Neck Cancer | Nasopharyngeal Carcinoma | Ovarian Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Classic Hodgkin LymphomaChina
-
Sumitomo Pharma America, Inc.TerminatedDepressive Episodes, Bipolar I DepressionUnited States, Bulgaria, Japan
-
EndocyteTerminated
-
Axonics, Inc.RecruitingUrinary Urge Incontinence (UUI) | Fecal Incontinence (FI) | Urinary Frequency (UF)Netherlands, United States
-
Kissei Pharmaceutical Co., Ltd.Completed
-
Coronado Biosciences, Inc.Unknown
-
RXi Pharmaceuticals, Corp.UnknownHypertrophic ScarUnited States, Honduras
-
BayerCompletedCarcinoma, Renal CellCanada, United States, Germany, United Kingdom, France, Netherlands
-
Carl Zeiss Meditec AGCompleted
-
RXi Pharmaceuticals, Corp.Completed
-
Hunan Province Tumor HospitalCompleted
-
RXi Pharmaceuticals, Corp.UnknownAge-related Macular Degeneration | Subfoveal Choroidal Neovascularization | Subretinal Scarring | Subretinal FibrosisUnited States
-
Taiho Pharmaceutical Co., Ltd.TerminatedAdvanced Colorectal CancerUnited States
-
Lytix Biopharma ASCompletedAtopic Dermatitis | Gram-positive, Skin Infections | Mild Eczema/DermatosesHungary
-
Kissei Pharmaceutical Co., Ltd.Completed
-
Kissei Pharmaceutical Co., Ltd.Completed
-
RXi Pharmaceuticals, Corp.CompletedHypertrophic ScarUnited States, Honduras
-
RXi Pharmaceuticals, Corp.CompletedKeloidUnited States, Dominican Republic
-
RXi Pharmaceuticals, Corp.CompletedCicatrix | Scar PreventionUnited States
-
KAI PharmaceuticalsNucleus Network LtdCompletedHyperparathyroidism, SecondaryAustralia
-
Seres Therapeutics, Inc.CompletedClostridioides Difficile InfectionUnited States, Canada
-
C. R. BardCompletedParoxysmal Atrial FibrillationCanada, Germany, United Kingdom
-
Medtronic VascularMedtronic Japan Co., Ltd.CompletedMyocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive DiseasesJapan
-
Lytix Biopharma ASCompletedNon-bullous ImpetigoDominican Republic
-
KAI PharmaceuticalsCompletedHyperparathyroidism, SecondaryUnited States, Australia
-
Roswell Park Cancer InstituteCompleted
-
TheradexUnknown
-
Pharma Holdings ASUniversity Hospital of North NorwayCompleted
-
Shanghai Simnova Biotechnology Co.,Ltd.Chinese PLA General HospitalRecruitingRecurrent Glioblastoma MultiformeChina
-
AllerganCompletedBreast ImplantationFrance, Spain, Germany, Israel, United Kingdom
-
Allergan MedicalCompletedBreast Augmentation | Breast Reconstruction | Revision of Augmentation or ReconstructionUnited States
-
Dongkook Pharmaceutical Co., Ltd.CompletedNasolabial FoldsKorea, Republic of
-
National Center for Research Resources (NCRR)National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Inhibrx, Inc.RecruitingConventional ChondrosarcomaUnited States, Spain, United Kingdom, France, Germany, Italy, Australia, Netherlands, Ireland
-
Seres Therapeutics, Inc.Approved for marketingClostridioides Difficile Infection
-
Seres Therapeutics, Inc.CompletedClostridium Difficile InfectionUnited States, Canada
-
TheradexUnknownLymphomaUnited States, Canada
-
Mario Negri Institute for Pharmacological ResearchCompleted
-
Hospital for Special Surgery, New YorkOslo University Hospital; Weill Medical College of Cornell UniversityCompleted
-
OncoPep, Inc.Not yet recruitingMetastatic Triple-Negative Breast Carcinoma
-
Pharma Holdings ASCTC Clinical Trial Consultants ABCompletedA Study to Evaluate the Safety and Efficacy of 3% LTX-109 for Nasal Decolonisation of StaphylococcusNasal Decolonization of Staphylococcus AureusSweden
-
Pyramid BiosciencesNot yet recruiting
-
Baskent UniversityCompletedLow Back Pain, Mechanical | Radiculopathy | Herniated Disk LumbarTurkey